Recombinant Human Interleukin-2: Unleashing Immune Power Against Cancer
ProcurenetShort description
Recombinant Human Interleukin-2 is a high-quality, pharmaceutical-grade product designed to bolster immune responses and battle cancer. Recognized for its potency in stimulating immunity and offering a robust defense against cancer, its key markets span across multiple continents from North America to Africa. The product is meticulously packaged to ensure safety and delivered within an estimated timeline of 25 days. For assurance of quality, samples are available on request.
-
Procurenet Team Tshim Sha Tsui
Hong Kong
3 years
Description
Recombinant Human Interleukin-2 (rHuIL-2) is an unparalleled alliance of biotechnology and medicine, formulated to offer a robust elevation in your immunity, and a vigorous line of defense against cancer. Engineered in pharmaceutical-grade purity, this product serves as a cornerstone of cancer immunotherapy and is pivotal in enhancing immune responses that aid in preventing and combating deadly malignancies.
Essential information about rHuIL-2 includes:
- Product Composition: Made up of Recombinant Human Interleukin-2, which is a type of cytokine signaling molecule in the immune system that modulates immunity and inflammatory response.
- Grade: Crafted in Pharmaceutical Grade which assures maximum purity and effectiveness.
- Intended Use: Primarily designed for immune response augmentation and a potent therapeutic agent for various cancer treatments.
- Key Markets: Global demand with key market coverage over North America, Central and South America, Western and Eastern Europe, Australasia, Asia, the Middle East, and Africa.
- Packaging: Designed to ensure optimal quality, each item is securely packed in a dedicated inner carton which is subsequently placed in an outer carton, housing 5 units.
- Delivery: Expedited delivery system ensuring order fulfillment within the estimated 25-day timeframe.
- Samples: To ensure our customer's utmost satisfaction, sample requests are readily entertained.
In accordance with scientific research, the regular use of Recombinant Human Interleukin-2 can drastically improve one's health status by boosting immunity and providing therapeutic effects for people undergoing cancer treatment. With a firm commitment to fostering health, Recombinant Human Interleukin-2 is set to create remarkable change in the lives of people across the world.
